Senescence-associated reprogramming promotes cancer stemness
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-)malignant cells. Key signalling components of the senescence machinery, such as p16 INK4a, p21 CIP1 and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness'). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from Eμ-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells are known to exert detrimental long-term effects on organ function and can promote tumorigenesis33,96,112,177,178.”
From COVID-19 and cellular senescence (2023) · cites this paper as [177]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the senescence programme is associated with enhanced stemness through cell- autonomous and cell- non- autonomous mechanisms”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous transcriptional or, more generally, functional changes in senescent cells, and the permanent need to actively maintain senescencesupporting transcription puts the stability of cell cycle arrest at risk, occasionally leading to the restoration of proliferative properties with a potentially detrimental effect on tumour suppression 5,79 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, inactivation of Tp53 , the genes encoding either one of the three Rb family members or Suv39h1 in already senescent cells enables cell cycle re- entry out of the terminal arrest condition 5,125,126 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, retained senescence- associated gain of stemness in senescence escapers has been demonstrated in samples derived from patients with relapsed diffuse large B cell lymphoma that exhibited strong enrichment for WNT signalling activity reminiscent of senescence- associated stemness 5 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Cited by
Items 501–600 of 1,000
p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
Souza, L. C. D. M. E., Faletti, A., Veríssimo, C. P., Stelling, M. P., & Borges, H. L. (2022) · Membranes · doi:10.3390/membranes12020202 · Cited by 20
Pacifico, F., Mellone, S., D’Incalci, M., Stornaiuolo, M., Leonardi, A., & Crescenzi, E. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115159 · Cited by 20
Thompson, E. L., Hu, J., & Niedernhofer, L. J. (2021) · Cancers · doi:10.3390/cancers13092241 · Cited by 20
Xin, Q., Chen, Z., Wei, W., & Wu, Y. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114970 · Cited by 21
Feng, D., Shi, X., You, J., Xiong, Q., Zhu, W., Wei, Q., & Yang, L. (2022) · PubMed · Cited by 20
Recent Advances in the Aging Microenvironment of Breast Cancer
Jiang, X., Shen, H., Xi, S., Fang, J., Lu, Y., Lu, Y., Zheng, J., & Fu, P. (2022) · Cancers · doi:10.3390/cancers14204990 · Cited by 19
Yan, K., He, Q., Lin, D., Liang, J., Chen, J., Xie, Z., & Chen, Z. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.035 · Cited by 19
Therapy-induced normal tissue damage promotes breast cancer metastasis
Perkins, D. W., Steiner, I., Haider, S., Robertson, D. M., Buus, R., O’Leary, L., & Isacke, C. M. (2023) · iScience · doi:10.1016/j.isci.2023.108503 · Cited by 21
Li, J., Qi, X., Lai, M., Zhou, J., Yuan, M., You, J., Liu, Q., Pan, J., Zhao, L., Ying, M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2407904121 · Cited by 20
Mitochondria-driven elimination of cancer and senescent cells
Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 20
Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem
Smigiel, J. M., Taylor, S. E., Bryson, B. L., Tamagno, I., Polak, K. L., & Jackson, M. W. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.26 · Cited by 20
Zhang, Z., Hong, Q., Zhang, Z., Xing, W.-Y., Xu, S., Tian, Q.-X., Ye, Q., Wang, H., Yu, D., Xie, D., et al. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111436 · Cited by 19
Cervical Cancer Stem-Like Cell Transcriptome Profiles Predict Response to Chemoradiotherapy
Zuccherato, L. W., Machado, C. M. T., Magalhães, W. C. S., Martins, P. R., Campos, L. S., Braga, L. D. C., Teixeira‐Carvalho, A., Martins‐Filho, O. A., Franco, T. M. R. D. F., de Paula, S. O. C., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.639339 · Cited by 19
Ortiz-Hernández, G. L., Sanchez-Hernández, E. S., Ochoa, P. T., Elix, C. C., Alkashgari, H. R., McMullen, J. R. W., Soto, U., Martinez, S. R., Osterman, C. J. D., Mähler, M., et al. (2021) · Cells · doi:10.3390/cells10102723 · Cited by 19
Sobeai, H. M. A., Alohaydib, M. H., Alhoshani, A., Alhazzani, K., Almutairi, M. M., Saleh, T., Gewirtz, D. A., & Alotiabi, M. R. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.12.004 · Cited by 20
Timofeev, O. N., & Stiewe, T. (2021) · Cancers · doi:10.3390/cancers13102422 · Cited by 19
The role of glycometabolic plasticity in cancer
Peng, Y., Yang, H., & Li, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153595 · Cited by 20
Qing, Y., Li, H., Zhao, Y., Hu, P., Wang, X., Yu, X., Zhu, M., Wang, H., Wang, Z., Guo, Q., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5529518 · Cited by 19
Yang, Z., Gao, S., Wong, C. C., Liu, W., Chen, H., Shang, H., Wu, Z. Y., Xu, L., Zhang, X., Wong, N., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6065 · Cited by 18
Tóth, F., Moftakhar, Z., Sotgia, F., & Lisanti, M. P. (2024) · Cells · doi:10.3390/cells13100841 · Cited by 19
Decoding T cell senescence in cancer: Is revisiting required?
Magkouta, S., Markaki, E., Evangelou, K., Petty, R., Verginis, P., & Gorgoulis, V. G. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.003 · Cited by 20
Saleh, T., Tyutyunyk‐Massey, L., Patel, N. H., Cudjoe, E. K., Alotaibi, M. R., & Gewirtz, D. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041427 · Cited by 20
Ye, Z., Che, H.-B., Zhang, T.-Y., Chen, Z., Tian, L., & Gu, D.-N. (2020) · Oncology Letters · doi:10.3892/ol.2020.12400 · Cited by 21
The molecular basis of immuno-radiotherapy
Koukourakis, I. M., TINIAKOS, D. G., Kouloulias, V., & Zygogianni, A. G. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2144960 · Cited by 18
Structural insight into Wnt signaling inhibition by Clostridium difficile toxin B
Chen, P., Tao, L., Liu, Z., Dong, M., & Jin, R. (2018) · FEBS Journal · doi:10.1111/febs.14681 · Cited by 18
Cellular Senescence and Immunosenescence in Melanoma: Insights From the Tumor Microenvironment
Xiong, L., & Cheng, J. (2025) · Cancer Medicine · doi:10.1002/cam4.71223 · Cited by 17
Cellular senescence in cancer: Friend or fraud?
Chen, Q., Liu, J., Wu, J., Xiang, X., Zhou, X., Mi, J., Wei, J., Zou, X., & Wu, A. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101363 · Cited by 20
Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions
Saleh, T., & Carpenter, V. J. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000361 · Cited by 17
Ripk3 signaling regulates HSCs during stress and represses radiation-induced leukemia in mice
Zhang, L., Luo, H., Ni, H., Liu, S., Xing, H., Zhang, J., Sellin, M., Breslin, P., Wei, W., Denning, M. F., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.04.009 · Cited by 17
Gao, C., Zhou, G., Cheng, M., Feng, L., Cao, P., & Zhou, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.956094 · Cited by 18
Wuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1477 · Cited by 18
Banerjee, P., Gaddam, N., Pandita, T. K., & Chakraborty, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032877 · Cited by 21
Oyama, K., Iwagami, Y., Kobayashi, S., Sasaki, K., Yamada, D., Tomimaru, Y., Noda, T., Asaoka, T., Takahashi, H., Tanemura, M., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34725 · Cited by 18
Senotherapy, cancer, and aging
Balducci, L., Falandry, C., & Monfardini, S. (2023) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2023.101671 · Cited by 19
Dormancy of cutaneous melanoma
Singvogel, K., & Schittek, B. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03278-5 · Cited by 17
From rest to repair: Safeguarding genomic integrity in quiescent cells
Leung, C. W. B., Wall, J., & Esashi, F. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103752 · Cited by 18
The cross-talk between B cells and macrophages
Su, Y., Liu, S., Long, C., Zhou, Z., Zhou, Y., & Tang, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113463 · Cited by 17
DNA Replication Stress Induced by Trifluridine Determines Tumor Cell Fate According to p53 Status
Kataoka, Y., Iimori, M., Fujisawa, R., Morikawa, T., Niimi, S., Wakasa, T., Saeki, H., Oki, E., Miura, D., Tsurimoto, T., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1051 · Cited by 18
Carpenter, V. J., Patel, B. B., Autorino, R., Smith, S. C., Gewirtz, D. A., & Saleh, T. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188424 · Cited by 18
Tang, M., Hernandez, L. L., Reginald-Opara, J. N., Svirskis, D. M., Leung, E. Y., Wang, H., & Wu, Z. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120659 · Cited by 18
Combining the past and present to advance immuno-radiotherapy of cancer
Koukourakis, I. M., & Koukourakis, M. I. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1974020 · Cited by 17
Bai, Y., Boath, J., White, G. R., Kariyawasam, U. G. I. U., Farah, C. S., & Darido, C. (2021) · Cancers · doi:10.3390/cancers13205123 · Cited by 18
Cellular senescence in neuroblastoma
Zanotti, S., Decaesteker, B., Vanhauwaert, S., Wilde, B. D., Vos, W. H. D., & Speleman, F. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01755-0 · Cited by 18
Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations
Lee, A. H., Peña, C. M., & Dawson, M. (2022) · Cancers · doi:10.3390/cancers14061418 · Cited by 17
Feunteun, J., Ostyn, P., & Delaloge, S. (2022) · iScience · doi:10.1016/j.isci.2022.104217 · Cited by 18
Chen, W., Zhang, W., Chen, M., Yang, C., Fang, T., Wang, H., Reid, L. M., & He, Z. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00714-4 · Cited by 17
Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
Etheridge, T. J., Damodaran, S., Schultz, A., Richards, K. A., Gawdzik, J. C., Yang, B., Cryns, V. L., & Jarrard, D. F. (2018) · Asian journal of urology · doi:10.1016/j.ajur.2018.09.001 · Cited by 17
Turano, P. S., Akbulut, E., Dewald, H. K., Vasilopoulos, T., Fitzgerald-Bocarsly, P., Herbig, U., & Martínez-Zamudio, R. I. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116795 · Cited by 16
Bazzar, W., Bocci, M., Hejll, E., Tabor, V., Hydbring, P., Grandien, A., Alzrigat, M., & Larsson, L. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1855740 · Cited by 16
Palazzo, A., Hernández‐Vargas, H., Goehrig, D., Médard, J., Vindrieux, D., Flaman, J., & Bernard, D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215850 · Cited by 17
Can 3D bioprinting solve the mystery of senescence in cancer therapy?
Shboul, S. A., DeLuca, V. J., Dweiri, Y. M., & Saleh, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101732 · Cited by 17
Senescence Promotes the Recovery of Stemness among Cancer Cells via Reprograming
Wang, D., & Liu, L. (2024) · Biomolecules · doi:10.3390/biom14030288 · Cited by 17
Persisting cancer cells are different from bacterial persisters
Decollogny, M., & Rottenberg, S. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.02.002 · Cited by 16
Photoacoustic polydopamine-indocyanine green (PDA-ICG) nanoprobe for detection of senescent cells
Hartono, M., Baker, A., Else, T. R., Evtushenko, A. S., Bohndiek, S. E., Muñoz‐Espín, D., & Fruk, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-79667-7 · Cited by 16
ALDH1 as a prognostic marker for lymph node metastasis in OSCC
Götz, C., Bissinger, O., Nobis, C.-P., Wolff, K. D., Drecoll, E., & Kolk, A. (2018) · Biomedical Reports · doi:10.3892/br.2018.1131 · Cited by 19
Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG
Lee, J. C., Kim, G. C., Lee, N. K., Kim, S. W., Cho, Y. S., Chung, S. W., Lee, Y. J., Chang, H. W., Byun, Y., & Kim, S. Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.012 · Cited by 15
Recent Advances in Senolysis for Age-Related Diseases
Aratani, S., & Nakanishi, M. (2023) · Physiology · doi:10.1152/physiol.00003.2023 · Cited by 19
Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer
Rowell, M., Deschênes‐Simard, X., Lopes‐Paciencia, S., Calvé, B. L., Kalegari, P., Mignacca, L., Ruiz, A. F., Guillon, J., Lessard, F., Bourdeau, V., et al. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2278945 · Cited by 19
Exploring replication stress and cellular senescence as key targets in novel cancer therapies
Ray, S. K., & Mukherjee, S. (2025) · Cancer Genetics · doi:10.1016/j.cancergen.2025.09.002 · Cited by 15
Cellular senescence in adult pulmonary hypertension: current state and future challenges
Lemay, S.-E. S., Kuwabara, Y., Bonnet, S., Potus, F., Provencher, S., Adnot, S., & Boucherat, O. (2025) · European Respiratory Review · doi:10.1183/16000617.0030-2025 · Cited by 16
Advances in the Study of CircRNAs in Tumor Drug Resistance
Wang, S., Qian, L., Cao, T., Xu, L., Jin, Y., Hu, H., Fu, Q., Li, Q., Wang, Y., Wang, J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.868363 · Cited by 17
Cellular uptake and retention studies of silica nanoparticles utilizing senescent fibroblasts
Perrigue, P. M., Henschke, A., Grześkowiak, B. F., Przysiecka, Ł., Jaskot, K., Mielcarek, A., Coy, E. L., & Moya, S. E. (2023) · Scientific Reports · doi:10.1038/s41598-022-26979-1 · Cited by 15
The epigenome and the many facets of cancer drug tolerance
Moore, P. C., Henderson, K. W., & Classon, M. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2022.12.002 · Cited by 15
Boylan, J., Byers, E., & Kelly, D. F. (2023) · Medical Research Archives · doi:10.18103/mra.v11i6.3994 · Cited by 17
Metabolic regulation of endothelial senescence
Le, N.-T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1232681 · Cited by 16
Song, Z., Wang, L., Ouyang, M., Xing, S., Liu, S., Sun, L., & Yu, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306969 · Cited by 17
Ding, Y., Sussman, J., Madden, K., Loftus, J. P., Chen, R. K., Falkenstein, C. D., Bárcenas-López, D. A., Hottman, D. A., Mathier, B., Yu, W., et al. (2025) · Blood · doi:10.1182/blood.2024026482 · Cited by 16
Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control
Belenki, D., Richter‐Pechańska, P., Shao, Z., Bhattacharya, A., Lau, A., de Freitas, J. A. N. L. F., Kandler, G., Hick, T., Cai, X., Scharnagl, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57429-x · Cited by 16
Self-citationEmerging drug targets for colon cancer: A preclinical assessment
Crutcher, M. M., Baybutt, T. R., Kopenhaver, J. S., Snook, A. E., & Waldman, S. A. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2039119 · Cited by 15
Role of Senescence in Tumorigenesis and Anticancer Therapy
Stoczyńska-Fidelus, E., Węgierska, M., Kierasińska, A., Ciunowicz, D., & Rieske, P. (2022) · Journal of Oncology · doi:10.1155/2022/5969536 · Cited by 15
Cellular Senescence, a Novel Area of Investigation for Metastatic Diseases
Faggioli, F., Velarde, M. C., & Wiley, C. D. (2023) · Cells · doi:10.3390/cells12060860 · Cited by 16
Mitochondria in cell senescence: A Friend or Foe?
Chen, Q., Young, L. H., & Barsotti, R. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.019 · Cited by 15
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Gazzillo, A., Volponi, C., Soldani, C., Polidoro, M. A., Franceschini, B., Lleò, A., Bonavita, E., & Donadon, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010026 · Cited by 15
The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition
Mattiello, L., Rehim, S. S. A., Musella, M., Sistigu, A., Guarracino, A., Vitale, S., Corradi, F., Galassi, C., Sperati, F., Manic, G., et al. (2021) · Cancers · doi:10.3390/cancers13081957 · Cited by 15
Salazar-Terreros, M. J., & Vernot, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137350 · Cited by 15
Li, K., Tang, M., Tong, S., Wang, C., Sun, Q., Lv, M., Sun, X., Wang, T., & Jin, S. (2020) · APOPTOSIS · doi:10.1007/s10495-019-01586-0 · Cited by 15
Pan, Y., Gu, Z., Lyu, Y., Yang, Y., Chung, M., Pan, X., & Cai, S. (2022) · Rejuvenation Research · doi:10.1089/rej.2022.0021 · Cited by 18
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
Romaniello, D., Gelfo, V., Pagano, F., Sgarzi, M., Morselli, A., Girone, C., Filippini, D. M., D’Uva, G., & Lauriola, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1083743 · Cited by 15
p15INK4B is an alternative marker of senescent tumor cells in colorectal cancer
Park, S. S., Lee, Y., Park, S. H., Lim, S. B., Choi, Y. W., Shin, J. S., Kim, Y. H., Kim, J., & Park, T. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13170 · Cited by 16
Heterogeneity in leukemia cells that escape drug-induced senescence-like state
Miller, D., Kerkhofs, K., Aghababazadeh, F. A., Madahar, S. S., Minden, M. D., Hébert, J., Haibe‐Kains, B., Bayfield, M. A., & Benchimol, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06015-4 · Cited by 15
H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase
Menon, D. R., Hammerlindl, H., Gimenez, G., Hammerlindl, S., Zuegner, E., Torrano, J., Bordag, N., Emran, A. A., Giam, M., Denil, S. L. I. J., et al. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100993 · Cited by 14
Xiong, J., Fu, Y., Huang, J., Wang, Y., Jin, X., Wan, X., Huang, L., & Huang, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265525 · Cited by 14
McGrath, M. K., Abolhassani, A., Guy, L., Elshazly, A. M., Barrett, J. T., Mivechi, N. F., Gewirtz, D. A., & Schoenlein, P. V. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1298423 · Cited by 15
Xu, M., Xia, Z.-Y., Sun, J., Liu, C., An, Y., Xu, J., Zhang, S.-H., Zhong, X., Zeng, N., Ma, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395047 · Cited by 16
Tumor-Associated Senescent Macrophages, Their Markers, and Their Role in Tumor Microenvironment
Pukhalskaia, T. V., Yurakova, T. R., Bogdanova, D. A., & Demidov, O. N. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050055 · Cited by 15
Lee, M. K., Woo, S. R., Noh, J. K., Min, S., Kong, M., Lee, Y. C., Ko, S., & Eun, Y. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0738 · Cited by 14
Wang, Z., Chen, C., Ai, J., Gao, Y., Wang, L., Xia, S., Jia, Y., & Qin, Y. (2025) · MedComm · doi:10.1002/mco2.70048 · Cited by 18
Jiang, S.-L., Wang, D., Zou, C., Zhu, Z., Luo, C., & Wang, Z. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108906 · Cited by 17
Xagorari, M., Marmarinos, A., Kossiva, L., Baka, M., Doganis, D., Servitzoglou, M. K., Tsolia, M. N., Scorilas, A., Avgeris, M., & Gourgiotis, D. (2021) · Cancers · doi:10.3390/cancers13236064 · Cited by 14
Peña, C. M., Skipper, T. A., Hsu, J., Schechter, I., Ghosh, D., & Dawson, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-46055-6 · Cited by 14
Abu-Humaidan, A. H. A., Ismail, M. A., Ahmad, F. M., Shboul, S. A., Barham, R., Tadros, J. S., Alhesa, A., El‐Sadoni, M., Alotaibi, M. R., Ababneh, N. A., et al. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12727 · Cited by 14
Senescent Cells in IPF: Locked in Repair?
Meiners, S., & Lehmann, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606330 · Cited by 16
Chen, C., Wei, Y., Wei, L., Chen, J., Chen, X., Dong, X., He, J., Lin, L., Zhu, Y., Huang, H., et al. (2020) · Aging · doi:10.18632/aging.103284 · Cited by 14
Yang, F., Zhang, F., Ji, X., Jiang, X., Xue, M., Yu, H., Hu, X., & Bao, Z. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012974 · Cited by 15
Multi-omics and single cell characterization of cancer immunosenescence landscape
Wei, Q., Chen, R., He, X., Qu, Y., Yan, C., Liu, X., Liu, J., Luo, J., Yu, Z., Hu, W., et al. (2024) · Scientific Data · doi:10.1038/s41597-024-03562-z · Cited by 14
Pogacar, Z., Johnson, J. L., Krenning, L., De Conti, G., Jochems, F., Lieftink, C., Velds, A., Wardak, L., Groot, K., Schepers, A., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0273182 · Cited by 13
Rational modification of PROTACs for tumor-selective protein degradation
Fu, Z., Pan, M., Yang, C., Hou, H., & Li, J. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115775 · Cited by 15
Tumor exosomes impact functional hallmarks of cancer
Laein, M. H., Thinakaran, Y., Katoueezadeh, M., Iyappan, R., Baker, J., Kalailingam, P., Ngan, S. C., McCarthy, N. E., Klentrou, P., Tsiani, E., et al. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10333-2 · Cited by 13
Novais, E. J., Ottone, O. K., Jagannath, S., Akande, E. J., Barve, R. A., & Risbud, M. V. (2026) · Bone Research · doi:10.1038/s41413-026-00526-4 · Cited by 13
Non-Genomic Hallmarks of Aging—The Review
Holmannová, D., Borský, P., Kovaříková, H., Štveráková, T., Vošmik, M., Hruška, L., Fiala, Z., & Borská, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015468 · Cited by 16
Metadata
- Authors
- Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., Mendoza-Parra, M. A., Kanashova, T., Metzner, M., Pardon, K., Reimann, M., Trumpp, A., Dörken, B., Zuber, J., Gronemeyer, H., Hummel, M., Dittmar, G., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Max Delbrück Center (DE)
- Centre National de la Recherche Scientifique (FR)
- Research Institute of Molecular Pathology (AT)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7686
- Pages
- 96-100
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777786283
- Cited by
- 1,131
- References
- 60
- Citations by year
- 2026: 110 · 2025: 137 · 2024: 154 · 2023: 181 · 2022: 149 · 2021: 140 · 2020: 125 · 2019: 84 · 2018: 49 · 2017: 1
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, cancer stem cells, chemotherapy-induced senescence, senescence escape, Wnt signaling, H3K9me3, p53, p16INK4a, p21, B-cell lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, hematologic malignancies, clonogenic growth, self-renewal
- MeSH terms
- Animals, Clone Cells, Female, Humans, Male, Mice, Transgenic, Phenotype, Neoplastic Stem Cells, Biomarkers, Lymphoma, B-Cell, Cellular Senescence, Cell Line, Tumor, Cell Proliferation, Mice, Cell Cycle Checkpoints, Wnt Signaling Pathway, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.